cipla

Cipla exports raw materials, intermediates, prescription drugs, OTC products and veterinary products. Cipla also offers technology for products and processes.

Cipla's manufacturing facilities have been approved by the following regulatory authorities:

• Food and Drug Administration (FDA), USA
• Medicines and Healthcare products Regulatory Agency (MHRA), UK
• Therapeutic Goods Administration (TGA), Australia
• Medicines Control Council (MCC), South Africa
• National Institute of Pharmacy (NIP), Hungary
• Pharamaceutical Inspection Convention (PIC), Germany
• World Health Organisation (WHO)
• Department of Health, Canada
• State Institute for the Control of Drugs, Slovak Republic
• ANVISA, Brazil

• Therapeutic Vaccines (17/08/2010)
• Therapeutic Cancer Vaccines (07/05/2010)
• Medical Imaging (15/02/2010)

• Wockhardt (09/08/2007)
• Real Regulatory (09/08/2007)
• Nycomed (08/08/2007)
• Kurtsan (08/08/2007)
• Indoco (08/08/2007)
• Hikma (08/08/2007)
• Heaton (08/08/2007)
• Galenika (08/08/2007)
• Farmal (08/08/2007)